Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Beta-lactamase inhibitor CB-618 pharmacokinetics-pharmacodynamics characterized with other agents

Sep. 21, 2015

FDA awards fast track designation to ZMapp for Ebola virus disease

Sep. 21, 2015

FDA grants QIDP designation to Cempra's fusidic acid antibiotic

Sep. 21, 2015

Arch Biopartners completes preclinical validation studies for AB-569

Sep. 21, 2015

Topica Pharmaceuticals to advance 10% luliconazole program into phase III development

Sep. 21, 2015

Phase I/IIa results presented for ChAd-EBO-Z Ebola vaccine

Sep. 18, 2015

Proof-of-concept study shows promise of novel antimalarial KAF-156

Sep. 18, 2015

New malaria vaccine trial shows lack of efficacy

Sep. 18, 2015

Otsuka launches Olanedine antiseptic

Sep. 18, 2015

Viamet's VT-1129 obtains FDA's QIDP designation for cryptococcal meningitis

Sep. 17, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...